$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

$lgnd Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000088616318000030 Filed on March 01, 2018

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$50.47M	$33.38M	$28.00M
YoY Change	32.16%	54.38%	43.41%
Cost Of Revenue	$1.740M	$2.385M	$903.0K
YoY Change	-40.0%	138.74%	25.42%
Gross Profit	$48.73M	$30.99M	$27.09M
YoY Change	38.08%	50.29%	44.1%
Gross Profit Margin	96.56%	92.85%	96.77%
Selling, General & Admin	$1.770M	$7.030M	$6.550M
YoY Change	-73.3%	11.41%	-4.52%
% of Gross Profit	3.63%	22.68%	24.18%
Research & Development	$14.61M	$4.759M	$4.822M
YoY Change	127.93%	-19.31%	-1.87%
% of Gross Profit	29.98%	15.36%	17.8%
Depreciation & Amortization	$4.100M	$2.000M	$2.600M
YoY Change	36.67%	-31.03%	2500.0%
% of Gross Profit	8.41%	6.45%	9.6%
Operating Expenses	$20.37M	$4.759M	$4.822M
YoY Change	29.25%	-19.31%	-1.87%
Operating Profit	$28.36M	$16.49M	$13.02M
YoY Change	45.21%	201.74%	227.92%
Interest Expense	-$1.470M	$3.386M	$3.341M
YoY Change	-87.75%	8.66%	9.51%
% of Operating Profit	-5.18%	20.53%	25.67%
Other Income/Expense, Net	$3.790M	-$4.422M	-$4.715M
YoY Change	-3015.38%	3.92%	-66.37%
Pretax Income	$30.67M	$12.07M	$8.300M
YoY Change	324.2%	896.78%	-182.58%
Income Tax	-$14.31M	$11.86M	$22.42M
% Of Pretax Income	-46.65%	98.29%	270.11%
Net Earnings	-$42.48M	$67.36M	$73.16M
YoY Change	1259.42%	6309.32%	-1285.74%
Net Earnings / Revenue	-84.18%	201.83%	261.33%
Basic Earnings Per Share	-$2.02	$3.19	$3.45
Diluted Earnings Per Share	-$2.02	$2.80	$2.99
COMMON SHARES
Basic Shares Outstanding	21.07M shares	21.15M shares	21.21M shares
Diluted Shares Outstanding	21.07M shares	24.05M shares	24.44M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$201.7M	$202.3M	$172.6M
YoY Change	43.05%	63.01%	61.31%
Cash & Equivalents	$20.62M	$32.74M	$60.22M
Short-Term Investments	$181.0M	$169.5M	$112.4M
Other Short-Term Assets	$1.514M	$1.112M	$1.072M
YoY Change	-30.39%	-59.65%	-58.8%
Inventory	$4.373M	$5.007M	$6.809M
Prepaid Expenses	$1.017M
Receivables	$25.60M	$12.80M	$13.50M
Other Receivables	$3.900M	$3.000M	$3.200M
Total Short-Term Assets	$237.0M	$224.2M	$197.2M
YoY Change	45.36%	59.36%	55.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.212M	$3.526M	$1.875M
YoY Change	131.56%	93.1%	58.76%
Goodwill	$85.96M	$72.21M	$72.21M
YoY Change	19.05%	-0.21%	-0.21%
Intangibles	$228.6M	$196.6M	$199.3M
YoY Change	11.67%	-5.23%	-5.17%
Long-Term Investments	$6.438M	$5.137M	$6.014M
YoY Change	-22.85%	-70.37%	-67.9%
Other Assets	$4.859M	$2.028M	$1.668M
YoY Change	178.61%	16.28%	176.62%
Total Long-Term Assets	$434.0M	$438.1M	$442.8M
YoY Change	-1.03%	-4.79%	-9.67%
TOTAL ASSETS
Total Short-Term Assets	$237.0M	$224.2M	$197.2M
Total Long-Term Assets	$434.0M	$438.1M	$442.8M
Total Assets	$671.0M	$662.3M	$640.0M
YoY Change	11.54%	10.23%	3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.259M	$3.617M	$1.799M
YoY Change	-17.37%	31.19%	-22.99%
Accrued Expenses	$7.377M	$6.423M	$5.325M
YoY Change	15.32%	-3.78%	7.55%
Deferred Revenue	$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$224.5M	$221.6M	$218.6M
YoY Change	5.45%	5.47%	5.3%
Total Short-Term Liabilities	$238.9M	$231.7M	$225.8M
YoY Change	5.17%	2.46%	2.49%
LONG-TERM LIABILITIES
Long-Term Debt	$18.90M	$21.60M	$24.30M
YoY Change	-36.15%	-32.71%	-29.97%
Other Long-Term Liabilities	$4.248M	$695.0K	$915.0K
YoY Change	518.34%	70.34%	129.9%
Total Long-Term Liabilities	$4.248M	$695.0K	$915.0K
YoY Change	518.34%	70.34%	129.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$238.9M	$231.7M	$225.8M
Total Long-Term Liabilities	$4.248M	$695.0K	$915.0K
Total Liabilities	$252.4M	$237.6M	$230.6M
YoY Change	9.38%	3.08%	2.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$400.9M	-$393.9M	-$402.3M
YoY Change	-7.01%	-7.96%	0.29%
Common Stock	$21.00K	$21.00K	$21.00K
YoY Change	0.0%	-25.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$399.8M	$403.2M	$385.1M
YoY Change
Total Liabilities & Shareholders Equity	$671.0M	$662.3M	$640.0M
YoY Change	11.54%	10.23%	3.77%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	-$42.48M	$67.36M	$73.16M
YoY Change	1259.42%	6309.32%	-1285.74%
Depreciation, Depletion And Amortization	$4.100M	$2.000M	$2.600M
YoY Change	36.67%	-31.03%	2500.0%
Cash From Operating Activities	$31.30M	$22.70M	$15.40M
YoY Change	49.05%	22.7%	48.08%
INVESTING ACTIVITIES
Capital Expenditures	-$2.200M		-$100.0K
YoY Change			-99.46%
Acquisitions
YoY Change
Other Investing Activities	-$34.00M	-$51.70M	$34.30M
YoY Change	-60.74%	-991.38%	-6.54%
Cash From Investing Activities	-$36.20M	-$51.50M	$34.20M
YoY Change	-58.25%	-1130.0%	86.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.200M	1.400M	0.000
YoY Change	242.86%	-12.5%	-100.0%
NET CHANGE
Cash From Operating Activities	31.30M	22.70M	15.40M
Cash From Investing Activities	-36.20M	-51.50M	34.20M
Cash From Financing Activities	-7.200M	1.400M	0.000
Net Change In Cash	-12.10M	-27.40M	49.60M
YoY Change	-82.15%	-209.16%	64.24%
FREE CASH FLOW
Cash From Operating Activities	$31.30M	$22.70M	$15.40M
Capital Expenditures	-$2.200M		-$100.0K
Free Cash Flow	$33.50M		$15.50M
YoY Change	59.52%		-46.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000886163
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21204264	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	2200000000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	LIGAND PHARMACEUTICALS INC
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015Q4	lgnd	Business Acquisition Contingent Consideration Potential Cash Payment At End Of Period BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod	13500000	USD
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2015	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	1333000	USD
CY2016	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	646000	USD
CY2017	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	1007000	USD
CY2016	lgnd	Additional Revenue Royaltyto Acquiree Shareholders Percent AdditionalRevenueRoyaltytoAcquireeShareholdersPercent	0.1
CY2017	lgnd	Business Acquisition Contingent Consideration Potential Cash Payment Additions BusinessAcquisitionContingentConsiderationPotentialCashPaymentAdditions	8400000	USD
CY2016Q4	lgnd	Business Acquisition Contingent Consideration Potential Cash Payment At End Of Period BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod	8100000	USD
CY2017Q4	lgnd	Business Acquisition Contingent Consideration Potential Cash Payment At End Of Period BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod	14000000	USD
CY2015	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	6058000	USD
CY2016	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	27048000	USD
CY2017	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	30347000	USD
CY2016Q4	lgnd	Commercial License Rights CommercialLicenseRights	25821000	USD
CY2017Q4	lgnd	Commercial License Rights CommercialLicenseRights	19526000	USD
CY2015	lgnd	Convertible Notes Receivable Fair Value Period Increase Decrease ConvertibleNotesReceivableFairValuePeriodIncreaseDecrease	-800000	USD
CY2016	lgnd	Convertible Notes Receivable Fair Value Period Increase Decrease ConvertibleNotesReceivableFairValuePeriodIncreaseDecrease	-200000	USD
CY2016Q4	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	5088000	USD
CY2017Q4	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	4703000	USD
CY2016Q4	lgnd	Deferred Tax Assets Present Value Of Royalties DeferredTaxAssetsPresentValueOfRoyalties	591000	USD
CY2017Q4	lgnd	Deferred Tax Assets Present Value Of Royalties DeferredTaxAssetsPresentValueOfRoyalties	0	USD
CY2016Q4	lgnd	Deferred Tax Assets Property Plant And Equipment And Intangible Assets DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets	4385000	USD
CY2017Q4	lgnd	Deferred Tax Assets Property Plant And Equipment And Intangible Assets DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets	1984000	USD
CY2016Q4	lgnd	Deferred Tax Liabilites Finite Lived Intangible Assets DeferredTaxLiabilitesFiniteLivedIntangibleAssets	68631000	USD
CY2017Q4	lgnd	Deferred Tax Liabilites Finite Lived Intangible Assets DeferredTaxLiabilitesFiniteLivedIntangibleAssets	48237000	USD
CY2016Q4	lgnd	Deferred Tax Liabilites Indefinite Lived Intangible Assets DeferredTaxLiabilitesIndefiniteLivedIntangibleAssets	3963000	USD
CY2017Q4	lgnd	Deferred Tax Liabilites Indefinite Lived Intangible Assets DeferredTaxLiabilitesIndefiniteLivedIntangibleAssets	2414000	USD
CY2016Q4	lgnd	Deferred Tax Liabilities Fair Value Adjustment DeferredTaxLiabilitiesFairValueAdjustment	52000	USD
CY2017Q4	lgnd	Deferred Tax Liabilities Fair Value Adjustment DeferredTaxLiabilitiesFairValueAdjustment	243000	USD
CY2016Q4	lgnd	Deposits Liabilities Noncurrent DepositsLiabilitiesNoncurrent	43000	USD
CY2017Q4	lgnd	Deposits Liabilities Noncurrent DepositsLiabilitiesNoncurrent	43000	USD
CY2017	lgnd	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount	4700000	USD
CY2015	lgnd	Equity Receivedin Repaymentof Note Receivable EquityReceivedinRepaymentofNoteReceivable	0	USD
CY2016	lgnd	Equity Receivedin Repaymentof Note Receivable EquityReceivedinRepaymentofNoteReceivable	1200000	USD
CY2017	lgnd	Equity Receivedin Repaymentof Note Receivable EquityReceivedinRepaymentofNoteReceivable	0	USD
CY2014Q3	lgnd	Exercise Priceof Convertible Bond Hedge ExercisePriceofConvertibleBondHedge	75.05
CY2016	lgnd	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Contingent Liabilities FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities	3400000	USD
CY2017	lgnd	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Contingent Liabilities FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities	2500000	USD
CY2015	lgnd	Income Tax Reconciliation Change In Uncertain Tax Positions IncomeTaxReconciliationChangeInUncertainTaxPositions	-27188000	USD
CY2016	lgnd	Income Tax Reconciliation Change In Uncertain Tax Positions IncomeTaxReconciliationChangeInUncertainTaxPositions	-1423000	USD
CY2017	lgnd	Income Tax Reconciliation Change In Uncertain Tax Positions IncomeTaxReconciliationChangeInUncertainTaxPositions	-1308000	USD
CY2015	lgnd	Income Tax Reconciliation Contingent Value Rights IncomeTaxReconciliationContingentValueRights	1684000	USD
CY2016	lgnd	Income Tax Reconciliation Contingent Value Rights IncomeTaxReconciliationContingentValueRights	1225000	USD
CY2017	lgnd	Income Tax Reconciliation Contingent Value Rights IncomeTaxReconciliationContingentValueRights	903000	USD
CY2015	lgnd	Income Tax Reconciliation Expired Tax Credits Research IncomeTaxReconciliationExpiredTaxCreditsResearch	304000	USD
CY2016	lgnd	Income Tax Reconciliation Expired Tax Credits Research IncomeTaxReconciliationExpiredTaxCreditsResearch	-1525000	USD
CY2017	lgnd	Income Tax Reconciliation Expired Tax Credits Research IncomeTaxReconciliationExpiredTaxCreditsResearch	-2821000	USD
CY2015	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivableand Warrant IncreaseDecreaseinFairValueofConvertibleDebtReceivableandWarrant	-765000	USD
CY2016	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivableand Warrant IncreaseDecreaseinFairValueofConvertibleDebtReceivableandWarrant	462000	USD
CY2017	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivableand Warrant IncreaseDecreaseinFairValueofConvertibleDebtReceivableandWarrant	4032000	USD
CY2017	lgnd	Lease Expiration Year Maximum LeaseExpirationYearMaximum	2023
CY2016Q4	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	2916000	USD
CY2017Q4	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	9258000	USD
CY2017	lgnd	Maturity Period Of Highly Liquid Securities Maximum MaturityPeriodOfHighlyLiquidSecuritiesMaximum	P3M
CY2015	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-5013000	USD
CY2016	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-3334000	USD
CY2017	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-2580000	USD
CY2017Q4	lgnd	Operating Leases Future Minimum Payments Due After Four Years OperatingLeasesFutureMinimumPaymentsDueAfterFourYears	50000	USD
CY2017Q4	lgnd	Operating Leases Future Minimum Payments Due After Four Years Net OperatingLeasesFutureMinimumPaymentsDueAfterFourYearsNet	50000	USD
CY2017Q4	lgnd	Operating Leases Future Minimum Payments Due Net OperatingLeasesFutureMinimumPaymentsDueNet	2743000	USD
CY2017Q4	lgnd	Operating Leases Future Minimum Payments Due Next Twelve Months Net OperatingLeasesFutureMinimumPaymentsDueNextTwelveMonthsNet	734000	USD
CY2017Q4	lgnd	Operating Leases Future Minimum Payments Duein Oneand Two Years OperatingLeasesFutureMinimumPaymentsDueinOneandTwoYears	1701000	USD
CY2017Q4	lgnd	Operating Leases Future Minimum Payments Duein Oneand Two Years Net OperatingLeasesFutureMinimumPaymentsDueinOneandTwoYearsNet	1340000	USD
CY2017Q4	lgnd	Operating Leases Future Minimum Payments Duein Threeand Four Years OperatingLeasesFutureMinimumPaymentsDueinThreeandFourYears	619000	USD
CY2017Q4	lgnd	Operating Leases Future Minimum Payments Duein Threeand Four Years Net OperatingLeasesFutureMinimumPaymentsDueinThreeandFourYearsNet	619000	USD
CY2015	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	6740000	USD
CY2016	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	8800000	USD
CY2016	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	8777000	USD
CY2017	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	5000000	USD
CY2017	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	4998000	USD
CY2015	lgnd	Purchasefor Commercial License Rights PurchaseforCommercialLicenseRights	4030000	USD
CY2016	lgnd	Purchasefor Commercial License Rights PurchaseforCommercialLicenseRights	17695000	USD
CY2017	lgnd	Purchasefor Commercial License Rights PurchaseforCommercialLicenseRights	0	USD
CY2016	lgnd	Revenue Royaltyto Acquiree Shareholders Percent RevenueRoyaltytoAcquireeShareholdersPercent	0.2
CY2017	lgnd	Sales Returns Restocking Fee Percent SalesReturnsRestockingFeePercent	0.2
CY2016	lgnd	Threshold Revenue Amountto Trigger Additional Royalty Payments ThresholdRevenueAmounttoTriggerAdditionalRoyaltyPayments	35000000.0	USD
CY2016	lgnd	Threshold Revenue Amountto Trigger Royalty Payments ThresholdRevenueAmounttoTriggerRoyaltyPayments	15000000.0	USD
CY2016Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	311000	USD
CY2017Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	497000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2734000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2259000	USD
CY2015	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2016	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-348000	USD
CY2017	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	81000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6397000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7377000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	829000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	430000	USD
CY2016Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	942000	USD
CY2017Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	954000	USD
CY2016Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	899000	USD
CY2017Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	396000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1571000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1862000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2743000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2486000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	769653000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	798205000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-39628000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	10065000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	10704000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12458000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18893000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160203000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24916000	USD
CY2014Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	11600000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	12458000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	18893000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	24915000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	10274000	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	10925000	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11619000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10600000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11300000	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3333000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3544000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	335000	shares
CY2016Q4	us-gaap	Assets Assets	601585000	USD
CY2017Q4	us-gaap	Assets Assets	671021000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	163053000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	237021000	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-5013000	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-3334000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-2580000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97428000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18752000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20620000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-62775000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-78676000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1868000	USD
CY2015	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	247000	USD
CY2016	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2017	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2014Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	125.08
CY2014Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3264643	shares
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	33333333	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	33333333	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20909301	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21148665	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20909301	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21148665	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	229792000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3796000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12299000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	212910000	USD
CY2017Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	224529000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5807000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5571000	USD
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5366000	USD
CY2015	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	2375000	USD
CY2016	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	10643000	USD
CY2017	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	12120000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	11000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	261000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	18000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	33000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	372000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	111000	USD
CY2016Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	29563000	USD
CY2016Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	29600000	USD
CY2017Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	18859000	USD
CY2017Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	18900000	USD
CY2015	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	28190000	USD
CY2016	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2017	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-167413000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	10534000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	44075000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2016Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	123891000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	84422000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	357000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	321000	USD
CY2016Q4	us-gaap	Deferred Revenue DeferredRevenue	0	USD
CY2017Q4	us-gaap	Deferred Revenue DeferredRevenue	173000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3525000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-24720000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-240000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	228000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	4432000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1609000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	17000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	5692000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	5137000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	213082000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	143040000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	123891000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	84422000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	197733000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	136053000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	150226000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	90272000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	19312000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	12117000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	26878000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	30677000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	943000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	845000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	578000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	354000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	45000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11714000	USD
CY2015	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	28000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15349000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6987000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	1196000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	737000	USD
CY2015	us-gaap	Depreciation Depreciation	200000	USD
CY2016	us-gaap	Depreciation Depreciation	200000	USD
CY2017	us-gaap	Depreciation Depreciation	400000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2627000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11290000	USD
CY2016	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	1139000	USD
CY2017	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2015	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0	USD
CY2016	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	731000	USD
CY2015	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0	USD
CY2016	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	731000	USD
CY2017	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0	USD
CY2015	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	0	USD
CY2016	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	400000	USD
CY2016	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	408000	USD
CY2017	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	0	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	11.61
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.83
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2603000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4085000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	900000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8345000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	6438000	USD
CY2017	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	870000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12800000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	12800000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	200000	USD
CY2016	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1100000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12800000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	12800000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3207000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3877000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1604000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9990000	USD
CY2017	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25398000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27653000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28653000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	72207000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	85959000	USD
CY2015	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2016	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2017	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	35329000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7960000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	57231000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	227444000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2367000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	12556000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	11.61
CY2016	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.11
CY2017	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.60
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	10.83
CY2016	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.11
CY2017	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.53
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.04
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.04
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5143000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-23132000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2048000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-192115000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3694000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3881000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	160000	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10354000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10327000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1114000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2242000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	25000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	32429000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3645000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37674000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44675000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-231370000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6283000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-4169000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-5756000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	32400000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	13198000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2786000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	20031000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	140000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	263000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4019000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2111000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-328000	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	391000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	386000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	175000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	622000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	28000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	38000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	157000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4027000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2369000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1713000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6489000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8525000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8358000	USD
CY2015	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	192132000	USD
CY2016	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-10697000	USD
CY2017	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-44518000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2227000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-8000	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-926000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	401000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	244000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	843000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-987000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-526000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-402000	USD
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	228584000	USD
CY2016Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	276912000	USD
CY2017	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	94000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	499000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1214000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	882000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	204705000	USD
CY2017Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	314543000	USD
CY2015	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11802000	USD
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12178000	USD
CY2017	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11400000	USD
CY2015	us-gaap	Interest Paid InterestPaid	1822000	USD
CY2016	us-gaap	Interest Paid InterestPaid	1838000	USD
CY2017	us-gaap	Interest Paid InterestPaid	1838000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	1923000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	4373000	USD
CY2016	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2017	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	230732000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	252374000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	601585000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	671021000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	227129000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	238868000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8360000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1515000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7523000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-112862000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-143192000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84177000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41727000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	63001000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	93568000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	229824000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	6608000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-6170000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	1051000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-3125000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-1636000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	5079000	USD
CY2016Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	3207000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	6058000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	8426000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-7007000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	12556000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2380000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2015	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	4290000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8000000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-35925000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10845000	USD
CY2017Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	3877000	USD
CY2017Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	3900000	USD
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	212910000	USD
CY2017Q4	us-gaap	Notes Payable Current NotesPayableCurrent	224529000	USD
CY2015	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	44585000	USD
CY2016Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	14552000	USD
CY2016Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	15552000	USD
CY2016Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	16153000	USD
CY2016Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	18831000	USD
CY2016	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	65088000	USD
CY2017Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	19051000	USD
CY2017Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	14980000	USD
CY2017Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	16882000	USD
CY2017Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	22113000	USD
CY2017	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	73026000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	27329000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	43885000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	68076000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3745000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1375000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1124000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1339000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2175000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1514000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1744000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4859000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1933000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	93000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	143000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-50000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2160000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-257000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1965000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	687000	USD
CY2015	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	107000	USD
CY2016	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	183000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	723000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	2253000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	400000	USD
CY2017	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1768000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2719000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5183000	USD
CY2016Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	287000	USD
CY2017Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	359000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	489000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3901000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1966000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	999000	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10074000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	92502000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	26653000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	93000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1850000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2156000	USD
CY2015	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	166025000	USD
CY2016	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	164438000	USD
CY2017	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	254258000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1864000	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1017000	USD
CY2015	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2016	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	300000	USD
CY2017	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	200000	USD
CY2015	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	0	USD
CY2016	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	0	USD
CY2017	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	7054000	USD
CY2015	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	57234000	USD
CY2016	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	118874000	USD
CY2017	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	109649000	USD
CY2015	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	16039000	USD
CY2016	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	24596000	USD
CY2017	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	86985000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8849000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6415000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4517000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	227444000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-1636000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	12556000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3390000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6074000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1819000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4212000	USD
CY2015	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2603000	USD
CY2016	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2352000	USD
CY2017	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	831000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	14700000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	25596000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11005000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21221000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26887000	USD
CY2016Q3	us-gaap	Revenues Revenues	21619000	USD
CY2016Q4	us-gaap	Revenues Revenues	38185000	USD
CY2016	us-gaap	Revenues Revenues	108973000	USD
CY2015	us-gaap	Revenues Revenues	71914000	USD
CY2016Q1	us-gaap	Revenues Revenues	29648000	USD
CY2017Q1	us-gaap	Revenues Revenues	29267000	USD
CY2016Q2	us-gaap	Revenues Revenues	19521000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-431127000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-400924000	USD
CY2017Q2	us-gaap	Revenues Revenues	27995000	USD
CY2017Q3	us-gaap	Revenues Revenues	33375000	USD
CY2017Q4	us-gaap	Revenues Revenues	50465000	USD
CY2017	us-gaap	Revenues Revenues	141102000	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	38194000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	59423000	USD
CY2017	us-gaap	Royalty Revenue RoyaltyRevenue	88685000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	27662000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22502000	USD
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22070000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	12458000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	18893000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	24915000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1431245	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	40.08
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3044	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	273353	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	104247000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	157340000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1754275	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1876332	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	42.12
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	53.17
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	157340000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1876332	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	53.17
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	31.58
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	79.74
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	112.58
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	138616000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y11M12D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M38D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M37D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y8M37D
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	122296000	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	181041000	USD
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	148252	shares
CY2015	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2016	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	77331000	USD
CY2017	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2015	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	8849000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	5416000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	-5558000	USD
CY2015Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	200000000.0	USD
CY2015Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2017Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	193600000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	341290000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	399788000	USD
CY2015	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	6120	shares
CY2016	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	40500	shares
CY2017	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	14000	shares
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	489000	USD
CY2016	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3901000	USD
CY2017	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1966000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24408000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	237282000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	341290000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	399788000	USD
CY2015	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3005000	USD
CY2016	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1109000	USD
CY2017	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	144000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8524000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	36452000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	38770000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	29363000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	450000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	160000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	10583000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	154000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	70000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1067000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	28224000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2408000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	109000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	26800000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-231700000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6300000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-8400000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21228000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22284000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20832000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22997000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20898000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20831000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23019000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23216000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23551000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21109000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23481000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19790000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20887000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20898000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20708000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20832000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20831000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20938000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21013000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21071000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21109000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21032000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	56000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
CY2017	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	141000	shares
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations of Business Risk</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash equivalents and investments. The Company invests its excess cash principally in United States government debt securities, investment grade corporate debt securities and certificates of deposit. The Company has established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates.</font></div></div>
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to the previously issued statement of operations for comparability purposes. These reclassifications had no effect on the reported net income (loss), stockholders' equity and operating cash flows as previously reported.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates</font></div></div>

Files In Submission

Name	View Source	Status
0000886163-18-000030-index-headers.html	Edgar Link	pending
0000886163-18-000030-index.html	Edgar Link	pending
0000886163-18-000030.txt	Edgar Link	pending
0000886163-18-000030-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
formofrsugrantnoticeexhibi.htm	Edgar Link	pending
indemnificationagreement-d.htm	Edgar Link	pending
indemnificationagreement-o.htm	Edgar Link	pending
lgnd-20171231.xml	Edgar Link	completed
lgnd-20171231.xsd	Edgar Link	pending
lgnd-20171231x10k.htm	Edgar Link	pending
lgnd-20171231_cal.xml	Edgar Link	unprocessable
lgnd-20171231_def.xml	Edgar Link	unprocessable
lgnd-20171231_lab.xml	Edgar Link	unprocessable
lgnd-20171231_pre.xml	Edgar Link	unprocessable
lgnd-rsugrantnoticeperform.htm	Edgar Link	pending
lgndexhibi41.htm	Edgar Link	pending
lgndexhibi41001.jpg	Edgar Link	pending
lgndexhibi41002.jpg	Edgar Link	pending
lgnd_123117xexhibit211.htm	Edgar Link	pending
lgnd_123117xexhibit231.htm	Edgar Link	pending
lgnd_123117xexhibit232.htm	Edgar Link	pending
lgnd_123117xexhibit311.htm	Edgar Link	pending
lgnd_123117xexhibit312.htm	Edgar Link	pending
lgnd_123117xexhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stockreturngraph2017.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

2017 Q4 Form 10-K Financial Statement

#000088616318000030 Filed on March 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND LIGAND PHARMACEUTICALS INC Stock $lgnd

2017 Q4 Form 10-K Financial Statement

#000088616318000030 Filed on March 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd